Resonance Specialities Ltd
Resonance Specialities Ltd is engaged in the business of manufacturing of chemicals like pyridine, picoline, cyanopyridine and their derivatives.[1]The company was formerly known as Armour Polymers Limited, was the first in India to manufacture Pyridines.
- Market Cap ₹ 146 Cr.
- Current Price ₹ 126
- High / Low ₹ 133 / 77.0
- Stock P/E 41.2
- Book Value ₹ 48.4
- Dividend Yield 0.79 %
- ROCE 12.6 %
- ROE 9.28 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- The company has delivered a poor sales growth of 10.5% over past five years.
- Debtor days have increased from 55.0 to 76.6 days.
- Promoter holding has decreased over last 3 years: -8.06%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
35.62 | 39.52 | 45.30 | 37.84 | 38.63 | 33.91 | 35.71 | 41.40 | 56.14 | 70.29 | 75.76 | 58.82 | 57.32 | |
34.68 | 37.36 | 42.19 | 36.59 | 35.62 | 31.89 | 35.06 | 36.51 | 48.39 | 56.04 | 59.01 | 51.99 | 51.69 | |
Operating Profit | 0.94 | 2.16 | 3.11 | 1.25 | 3.01 | 2.02 | 0.65 | 4.89 | 7.75 | 14.25 | 16.75 | 6.83 | 5.63 |
OPM % | 2.64% | 5.47% | 6.87% | 3.30% | 7.79% | 5.96% | 1.82% | 11.81% | 13.80% | 20.27% | 22.11% | 11.61% | 9.82% |
0.14 | 0.38 | -0.38 | 1.86 | 0.26 | 0.82 | 1.08 | 1.31 | 0.44 | 1.59 | 1.36 | 1.61 | 0.82 | |
Interest | 0.64 | 0.76 | 0.59 | 0.58 | 0.52 | 0.39 | 0.55 | 0.54 | 0.35 | 0.29 | 0.07 | 0.11 | 0.31 |
Depreciation | 1.08 | 1.15 | 1.10 | 1.16 | 1.12 | 1.06 | 1.15 | 0.91 | 0.92 | 0.98 | 1.75 | 1.48 | 1.48 |
Profit before tax | -0.64 | 0.63 | 1.04 | 1.37 | 1.63 | 1.39 | 0.03 | 4.75 | 6.92 | 14.57 | 16.29 | 6.85 | 4.66 |
Tax % | 17.19% | 25.40% | 0.96% | 7.30% | 27.61% | 25.90% | 2,700.00% | 32.63% | 20.38% | 27.73% | 24.06% | 27.01% | |
-0.53 | 0.46 | 1.03 | 1.28 | 1.19 | 1.03 | -0.77 | 3.20 | 5.51 | 10.52 | 12.36 | 5.00 | 3.53 | |
EPS in Rs | -0.46 | 0.40 | 0.89 | 1.11 | 1.03 | 0.89 | -0.67 | 2.77 | 4.77 | 9.11 | 10.71 | 4.33 | 3.05 |
Dividend Payout % | 0.00% | 0.00% | 56.02% | 45.08% | 0.00% | 0.00% | 0.00% | 0.00% | 20.94% | 10.97% | 9.34% | 23.08% |
Compounded Sales Growth | |
---|---|
10 Years: | 4% |
5 Years: | 11% |
3 Years: | 2% |
TTM: | -2% |
Compounded Profit Growth | |
---|---|
10 Years: | 27% |
5 Years: | 44% |
3 Years: | -9% |
TTM: | -45% |
Stock Price CAGR | |
---|---|
10 Years: | 28% |
5 Years: | 43% |
3 Years: | -2% |
1 Year: | 50% |
Return on Equity | |
---|---|
10 Years: | 13% |
5 Years: | 20% |
3 Years: | 21% |
Last Year: | 9% |
Balance Sheet
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 11.54 | 11.54 | 11.54 | 11.54 | 11.54 | 11.54 | 11.54 | 11.54 | 11.54 | 11.54 | 11.54 | 11.54 | 11.54 |
Reserves | 9.28 | 9.42 | 9.45 | 9.95 | 11.14 | 12.42 | 11.72 | 14.93 | 18.99 | 29.13 | 40.26 | 44.15 | 44.32 |
3.53 | 3.45 | 3.38 | 3.12 | 1.92 | 4.07 | 3.40 | 0.00 | 0.00 | 0.72 | 0.09 | 2.29 | 3.23 | |
7.93 | 8.74 | 9.77 | 9.95 | 7.76 | 11.75 | 10.19 | 11.70 | 10.60 | 13.25 | 4.89 | 7.81 | 4.59 | |
Total Liabilities | 32.28 | 33.15 | 34.14 | 34.56 | 32.36 | 39.78 | 36.85 | 38.17 | 41.13 | 54.64 | 56.78 | 65.79 | 63.68 |
17.65 | 16.56 | 15.22 | 14.26 | 13.86 | 15.06 | 14.60 | 14.07 | 14.11 | 15.90 | 13.83 | 19.91 | 19.93 | |
CWIP | 0.40 | 0.03 | 0.03 | 0.03 | 0.13 | 0.20 | 0.60 | 0.83 | 1.84 | 0.04 | 0.44 | 0.44 | 1.81 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | 0.75 | 0.12 | 0.00 | 0.00 |
14.23 | 16.56 | 18.89 | 20.27 | 18.37 | 24.52 | 21.65 | 23.27 | 25.08 | 37.95 | 42.39 | 45.44 | 41.94 | |
Total Assets | 32.28 | 33.15 | 34.14 | 34.56 | 32.36 | 39.78 | 36.85 | 38.17 | 41.13 | 54.64 | 56.78 | 65.79 | 63.68 |
Cash Flows
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.56 | 0.79 | 1.76 | 1.11 | 3.23 | 0.56 | 2.14 | 5.27 | 1.42 | 4.28 | 13.33 | -8.37 | |
-0.37 | 0.00 | -0.07 | -0.28 | -0.82 | -2.62 | -1.11 | -0.50 | -1.82 | -1.18 | -8.80 | 3.20 | |
-0.14 | -0.84 | -0.60 | -1.52 | -2.41 | 1.76 | -1.01 | -3.65 | 1.15 | 0.31 | -1.86 | 0.93 | |
Net Cash Flow | 0.05 | -0.05 | 1.09 | -0.69 | 0.01 | -0.30 | 0.02 | 1.11 | 0.76 | 3.42 | 2.66 | -4.24 |
Ratios
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 65.68 | 70.75 | 76.63 | 99.16 | 66.05 | 79.76 | 67.97 | 66.74 | 39.92 | 48.92 | 39.51 | 76.57 |
Inventory Days | 88.72 | 105.52 | 81.52 | 133.71 | 159.21 | 397.20 | 211.58 | 180.17 | 232.12 | 236.12 | 175.79 | 646.44 |
Days Payable | 62.78 | 69.49 | 68.68 | 116.18 | 108.07 | 262.26 | 127.21 | 138.98 | 114.32 | 120.62 | 17.35 | 137.50 |
Cash Conversion Cycle | 91.62 | 106.78 | 89.46 | 116.69 | 117.19 | 214.70 | 152.35 | 107.93 | 157.71 | 164.41 | 197.94 | 585.51 |
Working Capital Days | 84.95 | 94.02 | 83.15 | 100.80 | 91.94 | 128.09 | 114.27 | 93.19 | 81.92 | 102.61 | 143.09 | 210.86 |
ROCE % | 0.98% | 5.70% | 7.30% | 3.96% | 8.74% | 6.84% | 2.23% | 20.21% | 30.63% | 41.32% | 34.91% | 12.65% |
Documents
Announcements
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 1d
- Certificate Under Regulation 40 (9) Of SEBI (LODR) Regulations, 2015 1d
- Clarification On Price Movement 17 Apr
-
Clarification sought from Resonance Specialties Ltd
16 Apr - Exchange has sought clarification from Resonance Specialties Ltd on April 16, 2024 with reference to significant movement in price, in order to ensure that investors …
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 15 Apr
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Product Portfolio[1]
The company manufactures and markets specialty chemicals based on pyridine chemistry such as Lutidine, cyano Pyridines, picoline, collidines, nutritional products, feed supplements, APIs, vitamins, etc. Pyridine
is segmented as Pyridine, Beta picoline, Alpha picoline, and Gamma picoline. The Asia-Pacific region is the largest market for pyridine.